RT Journal Article
SR Electronic
T1 Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001406
DO 10.1136/jitc-2020-001406
VO 9
IS 1
A1 Blumendeller, Carolin
A1 Boehme, Julius
A1 Frick, Maximilian
A1 Schulze, Martin
A1 Rinckleb, Antje
A1 Kyzirakos, Christina
A1 Kayser, Simone
A1 Kopp, Maria
A1 Kelkenberg, Sabine
A1 Pieper, Natalia
A1 Bartsch, Oliver
A1 Hadaschick, Dirk
A1 Battke, Florian
A1 Stenzl, Arnulf
A1 Biskup, Saskia
YR 2021
UL http://jitc.bmj.com/content/9/1/e001406.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.